West Pharmaceutical Services WST Total Liabilities & Equity
Total Liabilities & Equity at other companies
Other financials
Where this comes from
Reported directly by West Pharmaceutical Services in its filing.
Tagged under the XBRL concept us-gaap:LiabilitiesAndStockholdersEquity.
The official record: West Pharmaceutical Services’s 10-Q, filed July 23, 2026, on SEC EDGAR. View the filing →
Ask your AI about West Pharmaceutical Services's total liabilities & equity.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is West Pharmaceutical Services's total liabilities & equity?
- West Pharmaceutical Services (WST) reported total liabilities & equity of $4.08B in Q2 2026.
- How has West Pharmaceutical Services's total liabilities & equity changed year-over-year?
- West Pharmaceutical Services's total liabilities & equity increased by 3.1% year-over-year, from $3.95B to $4.08B.
- What is the long-term trend for West Pharmaceutical Services's total liabilities & equity?
- Over 5 years (2020 to 2025), West Pharmaceutical Services's total liabilities & equity has grown at a 8.9% compound annual growth rate (CAGR), from $2.79B to $4.27B.
- What does total liabilities & equity mean?
- Total assets = total liabilities + total equity. This must always balance — a fundamental accounting identity.